Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 11, 2023

GLP-1 Agonists Combined With SGLT2 Inhibitors Reduce Weight in Patients With Type 1 Diabetes



Additional Info

Glucagon-like peptide-1 agonists combined with sodium-glucose cotransporter-2 inhibitors reduce weight in type 1 diabetes
Obesity 2023 Mar 01;31(3)716-723, E Al-Ozairi, M Irshad, E Taghadom, L Sojan, J Al Kandari, D Alroudhan, CW le Roux

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading